News

Prostate cancer drug now available to more patients with aggressive form of disease
Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...
'I don't look at myself as a dying person anymore': New drug that slows incurable breast cancer now available on the NHS
Professor Nicholas Turner, from the Institute of Cancer Research, tells Sky News that capivasertib is a "great success story ...
Breast cancer treatment breakthrough for patients as NHS approves new 'landmark' drug
Thousands with advanced breast cancer could live long lives thanks to a new drug approved on the NHS . Capivasertib, retailed ...
GlobalData on MSN1d
AstraZeneca’s oral breast cancer drug Truqap greenlit for NHS use
AstraZeneca’s Truqap (capivasertib) has been approved for use by the National Health Service (NHS) in England and Wales, ...
TheCable1d
UK approves ‘game-changing’ drug for advanced breast cancer treatment
The United Kingdom’s National Institute for Health and Care Excellence (NICE) has approved a “game-changing” twice-a-day pill ...
Weight loss drugs may be ‘game changer’ for breast cancer patients with lymphedema
GLP-1 drugs are blockbuster medications for weight loss and Type 2 diabetes. Now doctors are trying them for lymphedema, ...
UK approves 'landmark' breast cancer drug
A new drug that helps slow the spread of an incurable type of breast cancer has been approved for use in Britain's state-run ...
New Breast Cancer Drug Capivasertib Approved by NHS IN UK
International: Capivasertib, a breakthrough drug for advanced HR-positive HER2-negative breast cancer, has been approved by ...
Key mechanism behind prostate cancer drug resistance reveals potential new treatment strategy
A team of University of Kentucky Markey Cancer Center researchers has found the mechanism that grants prostate cancer ...
'Gamechanging' drug which slows progression of incurable breast cancer set to be available on NHS
A breakthrough cancer drug for those facing the advanced stages of the disease has been approved for the first time on the ...
The National Institute for Health and Care Excellence3h
Thousands of people a year could benefit from new twice-a-day tablet for advanced breast cancer
Today, we've recommended capivasertib (also called Truqap and made by AstraZeneca) with fulvestrant as an option for around 1,100 adults with hormone receptor (HR)-positive HER2-negative breast cancer ...